Guardant Health, Inc.
GH- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001576280
In the last 90 days, Guardant Health, Inc. insiders filed 0 open-market purchases and 9 sales; 603 institutions reported holding it in 13F filings for Q2 2026, worth $20.0B in total; ARK Invest is the only superinvestor holding it.
Key figures
- Market capClose on Nov 11, 2026
- $20.9B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $9.74M in total
- 9
- 13F holdersQ2 2026, +119 vs. previous quarter
- 603
- 13F valueReported value at the end of Q2 2026
- $20.0B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $982.0M
- +32.9% year over year
- Net income, FY2025
- -$416.3M
- No comparable prior period
- Free cash flow, FY2025
- -$233.1M
- No comparable prior period
- Revenue, Q3 FY2026
- $361.0M
- +36.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $416.3M (42.4% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 9.43M
- Shares sold short
- Change
- −2.24M
- −19.2% vs. previous
- Days to cover
- 5.38
- At average daily volume
Superinvestors holding GH, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Guardant Health, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Guardant Health, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2026 (view filing)5:02 PM ET | Oct 16 | 3 days | Tariq MusaDirector | SSale | −116 | $165.88 | −$19.2K | −1.0%11.6K after | 10b5-1 |
| Oct 15, 2026 (view filing)6:02 PM ET | Oct 14 | 1 day | Azar Alex M IIDirector | SSale | −69 | $159.89 | −$11.0K | −7.2%893 after | 10b5-1 |
| Sep 17, 2026 (view filing)5:11 PM ET | Sep 15 | 2 days | Chudova DaryaChief Technology Officer | SSale | −7.74K | $178.00 | −$1.38M | −9.9%70.6K after | |
| Sep 17, 2026 (view filing)5:10 PM ET | Sep 16 | 1 day | Krognes Steve E.Director | SSale | −6.67K | $175.74 | −$1.17M | −45.8%7.91K after | 4 lots |
| Sep 17, 2026 (view filing)5:09 PM ET | Sep 16 | 1 day | Azar Alex M IIDirector | SSale | −826 | $175.00 | −$144.6K | −50.0%825 after | 10b5-1 |
| Sep 17, 2026 (view filing)5:09 PM ET | Sep 16 | 1 day | Tariq MusaDirector | SSale | −116 | $175.00 | −$20.3K | −1.0%11.4K after | 10b5-1 |
| Sep 14, 2026 (view filing)6:11 PM ET | Sep 11 | 3 days | Kalia KumudChief Information Officer | SSale | −4.00K | $158.05 | −$632.2K | −9.1%39.8K after | |
| Aug 24, 2026 (view filing)5:21 PM ET | Aug 21 | 3 days | Talasaz AmirAliCo-Chief Executive Officer | SSale | −37.5K | $169.16 | −$6.34M | −50.0%37.5K after | 3 lots |
| Aug 18, 2026 (view filing)6:14 PM ET | Aug 17 | 1 day | Tariq MusaDirector | SSale | −116 | $156.45 | −$18.1K | −1.0%11.3K after | 10b5-1 |
| Aug 13, 2026 (view filing)7:21 PM ET | Aug 12 | 1 day | Monroe Terilyn J.Chief People Officer | SSale | −46.3K | $165.12 | −$7.65M | −66.8%23.0K after | 5 lots |
Top 10 13F holders, Q2 2026
See all 603 holdersThe largest institutional positions in Guardant Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,622,935 | $1.14B | 0.02% | −3,930,824−34.0% | Reduced |
| Price T Rowe Associates Inc | 6,514,952 | $977.4M | 0.10% | −508,737−7.2% | Reduced |
| Vanguard Capital Management LLC | 5,755,857 | $863.6M | 0.02% | +131,677+2.3% | Added |
| FMR LLC | 5,488,272 | $823.4M | 0.04% | +1,372,191+33.3% | Added |
| Vanguard Portfolio Management LLC | 5,445,785 | $817.0M | 0.04% | −392,207−6.7% | Reduced |
| Invesco Ltd. | 4,429,755 | $664.6M | 0.05% | −516,714−10.4% | Reduced |
| Goldman Sachs Group Inc | 3,775,895 | $566.5M | 0.06% | −659,944−14.9% | Reduced |
| Two Sigma Investments, LP | 3,719,301 | $558.0M | 0.42% | −510,230−12.1% | Reduced |
| Capital International Investors | 3,399,604 | $510.0M | 0.11% | −81,714−2.3% | Reduced |
| Deep Track Capital, LP | 3,393,312 | $509.1M | 7.50% | +55,071+1.6% | Added |
Holders of 5% or more of GH
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Guardant Health, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G | 5.80%7.73M shares | – | Feb 9, 20226 filings | Nov 5, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 5.20%6.90M shares | −2.30 ppfrom 7.50% | Apr 17, 20252 filings | Jul 28, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.02%6.59M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in GH3 members of Congress reported 12 trades in Guardant Health, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Oct 19, 2026 |  Jonathan L. Jackson House · IL | Buy | $15K-$50K |
| Dec 1, 2025 |  Sheldon Whitehouse Senate · RI | Buy | $1K-$15K |
| Mar 3, 2022 |  Donald S. Beyer, Jr. House · VA | Sell | $1K-$15K |
| Feb 1, 2022 | Donald S. Beyer, Jr. House · VA | Sell | $1K-$15K |
| Jan 1, 2022 | Donald S. Beyer, Jr. House · VA | Sell | $1K-$15K |
House · IL · Oct 19, 2026
Buy$15K-$50K
Senate · RI · Dec 1, 2025
Buy$1K-$15K
House · VA · Mar 3, 2022
Sell$1K-$15K
House · VA · Feb 1, 2022
Sell$1K-$15K
House · VA · Jan 1, 2022
Sell$1K-$15K